1224 Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer

Nilesh Deshpande; Anna Bianchi; Iago De Castro Silva; Bapu Surnar; Ifeanyichukwu Ogobuiro; Siddharth Mehra; Samara Singh; Vanessa Garrido; Nipun Merchant; Shanta Dhar; Jashodeep Datta

doi:10.1136/jitc-2022-SITC2022.1224

Article info

Regular and Young Investigator Award Abstracts

Immuno-Engineering

1224 Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer

Free

Authors

Nilesh Deshpande University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Anna Bianchi University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Iago De Castro Silva University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Bapu Surnar University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Ifeanyichukwu Ogobuiro University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Siddharth Mehra University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Samara Singh University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Vanessa Garrido University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Nipun Merchant University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Shanta Dhar University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles
Jashodeep Datta University of Miami Miller School of Medicine, Miami, FL, USA PubMed articles Google scholar articles

Citation

Deshpande N, Bianchi A, Silva IDC, et al

1224 Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1224

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password